logo
U.S. plans to combat spread of "man-eater" screwworms with $8.5M facility of flies in Texas

U.S. plans to combat spread of "man-eater" screwworms with $8.5M facility of flies in Texas

CBS News19-06-2025
The U.S. government on Wednesday released a five-prong policy initiative to stop the spread of New World screwworms in live cattle and other animal imports, including its plan to build an $8.5 million insect dispersal facility in Texas.
Agriculture Secretary Brooke Rollins said her department plans to open what amounts to a fly factory by the end of the year. The facility will breed millions of sterile New World screwworm (NWS) flies at Moore Air Base, according to the initiative. The male flies will then be released into the wild to mate with females and prevent them from laying eggs in wounds that become flesh-eating larvae.
It would be only the second facility for breeding such flies in the Western Hemisphere, joining one in Panama that had largely kept the flies from migrating further north until last year.
An adult New World screwworm fly (left) and a New World screwworm larvae (right).
Denise Bonilla/USDA Agricultural Research Service via AP
"The United States has defeated NWS before, and we will do it again," Rollins said during a news conference at the South Texas air base with other state and cattle industry officials.
Late last year, the Texas Parks and Wildlife Department warned outdoor enthusiasts to watch out for animals that may be impacted by the dangerous "man-eater" parasites from flies that lay eggs in open wounds, nostrils, eyes and mouths. Last month, the U.S. Department of Agriculture suspended imports of live cattle, horses and bison from Mexico.
The New World Screwworm has been making its way further north through the Americas, Texas officials said, and the fly's appearance in southern Mexico has worried agriculture and cattle industry officials and veterinarians' groups.
According to the USDA, the New World Screwworm "is a devastating pest." The scientific name for the parasite, Cochliomyia hominivorax, is roughly translated to "man-eater," according to the USDA's Animal and Plant Health Inspection Service.
"When NWS fly larvae (maggots) burrow into the flesh of a living animal, they cause serious, often deadly damage to the animal," the USDA says. "NWS can infest livestock, pets, wildlife, occasionally birds and, in rare cases, people."
The USDA also plans to spend $21 million to convert a facility for breeding fruit flies near Mexico's southernmost border with Guatemala into one for breeding sterile New World screwworm flies, but it won't be ready for 18 months.
The U.S. bred and released sterile New World screwworm flies into the wild decades ago, and it was largely banished from the country in the 1960s. Previously, it had been an annual scourge for cattle ranchers and dairy farmers, particularly in the Southeast.
Mexican Agriculture Secretary Julio Berdegué said Wednesday in a post on X that Rollins' plan "seems to us a positive step in different aspects, it will strengthen the joint Mexico-U.S. work."
"We trust the enthusiasm for cooperation that Secretary Rollins mentioned, and based on objective results and the reports from the USDA mission visiting us this week, we will be able to restart exports of our cattle as soon as possible," he said.
The new Texas facility would be built at Moore Air Base, less than 20 miles from the Mexico border, and the USDA said it would also consider building a companion fly-breeding center there so that up to 300 million flies could be produced a week. The Panama facility breeds about 100 million a week, and the one in Mexico could breed as many as 100 million, as well.
The USDA has said the flies have been detected as close as 700 miles from the U.S. border, and some U.S. agriculture and cattle industry officials have worried that if the migration isn't checked, the flies could reach the border by the end of summer. Pressure from the U.S. prompted Mexico to step up efforts to control the fly's spread.
Buck Wehrbein, a Nebraska cattle rancher and the president of the National Beef Cattlemen's Association, said Moore Air Base had a fly-breeding facility in the 1960s that helped eradicate it in the U.S.
While there are treatments for New World screwworm infestations, cattle industry officials still worry that farmers and ranchers could see huge economic losses. They, agriculture officials and scientists also said the larvae can infest any mammal, including household pets, and it has occasionally been seen in humans.
"The only way to protect the American cattle herd from the devastating threat of New World screwworm is by having a sufficient supply of sterile flies to push this pest away from our border," Wehrbein said.
Texas officials said they are grateful the U.S. is taking the screwworm threat seriously and are pleased with the plans for combating it, including the new facility in Texas.
Officials in other states are watching the fly's migration, as well, and see that having sterile male flies outnumber the non-sterile ones is crucial to checking its migration.
"We have a real concern about wildlife because of their ability to cross the border unchecked somewhat, whether it's feral pigs, deer, wild cattle, whatever the case may be," Kansas Animal Health Commissioner Justin Smith said in a recent interview. "There's an opportunity for them to be our exposure risk."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

2 dead and 58 sick from growing Legionnaires' disease cluster in New York City
2 dead and 58 sick from growing Legionnaires' disease cluster in New York City

Yahoo

time18 minutes ago

  • Yahoo

2 dead and 58 sick from growing Legionnaires' disease cluster in New York City

Two people have died and at least 58 people have been diagnosed with Legionnaires' disease in a cluster that broke out in the Harlem area of New York City last week, officials said on Monday. The New York City Health Department had reported on Thursday that one person had died and 22 people were sick in the cluster. MORE: 1 dead and at least 22 sick from Legionnaires' disease cluster in New York City 'People living or working in the area with flu-like symptoms, such as cough, fever, chills, muscle aches, or difficulty breathing should contact a health care provider immediately,' the department said in a statement on Monday. 'It is especially important for people at higher risk -- including those ages 50 and older, cigarette smokers, and people with chronic lung disease or compromised immune systems -- to get care if they have symptoms.' Legionnaires' disease is a type of pneumonia that is caused by the bacteria Legionella, which grows in warm water, health officials said, and people can get Legionnaires' disease by breathing in water vapor that contains Legionella bacteria. MORE: Teen suffers 'significant thermal burns' near Yellowstone geyser MORE: Man sentenced to time served for trying to open plane door, stab flight attendant in neck "Anyone in these zip codes with flu-like symptoms should contact a health care provider as soon as possible," said Acting Health Commissioner Dr. Michelle Morse. "Legionnaires' disease can be effectively treated if diagnosed early, but New Yorkers at higher risk, like adults aged 50 and older and those who smoke or have chronic lung conditions, should be especially mindful of their symptoms and seek care as soon as symptoms begin." Legionnaires' disease can be caused by plumbing systems where conditions are favorable for Legionella growth, such as cooling towers, whirlpool spas, hot tubs, humidifiers, hot water tanks and evaporative condensers of large air-conditioning systems, health officials said. People can get Legionnaires' disease by breathing in water vapor that contains Legionella bacteria, though officials reminded people that the disease cannot be transmitted from person to person and can be treated with antibiotics. MORE: Cocaine worth more than $1 million seized at Texas border, CPB says The respiratory disease takes its name from an outbreak at the Pennsylvania American Legion convention held at the Bellevue-Stratford Hotel in Philadelphia in July 1976 and the bacterium believed to be responsible is found in soil and grows in water, such as air-conditioning ducts, storage tanks and rivers. No details about the two people who died have been released by officials as of Tuesday. Solve the daily Crossword

Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)

Yahoo

time18 minutes ago

  • Yahoo

Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)

First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025 UK Clinical Trial Application (CTA) approval shortly follows U.S. IND clearance and granting of European Medicine Agency (EMA) orphan drug designation, enabling readiness for initiation across sites in both the U.S. and Europe PS-002, Purespring's lead precision nephrology programme, targets the complement pathway known to be a driver of IgA nephropathy and is supported by a wealth of preclinical data London – 5 August 2025 - Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, today announces that its UK Clinical Trial Application (CTA) for a planned Phase I/II study of PS-002, Purespring's lead programme, in patients with IgA nephropathy (IgAN) has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the NHS Health Research Authority (HRA) and Research Ethics Committee (REC). 'The CTA approval for our Phase I/II clinical trial of PS-002 represents another key milestone as we complete our transition to a clinical-stage precision nephrology company,' said Haseeb Ahmad, Purespring's Chief Executive Officer. 'Building on the recent FDA IND clearance and EMA orphan drug designation, this further validates the potential of our podocyte-targeting approach to go beyond symptom management and directly target kidney disease at its source. Looking ahead, we are committed to working closely with regulators and sites across the U.S. and Europe with the view to expand the therapeutic options available for people living with IgAN.' PS-002 was developed to target the underlying cause of many kidney diseases by modulating complement activation in the kidney via precision targeting of podocytes. The programme is initially focused on the treatment of IgA nephropathy (IgAN), a rare and chronic autoimmune kidney disease that primarily affects young adults. In IgAN, aberrant immunoglobin A (IgA) protein becomes trapped in the kidney's filters, known as the glomeruli, causing complement activation, inflammation, damage and scarring. A significant proportion of affected patients will go on to develop kidney failure despite currently available therapies. The Phase I/II clinical trial, which is expected to enroll its first patient in Q4 2025, will evaluate local administration of PS-002 to treat IgAN. In the Phase 1 part of the Phase I/II study, the main read-outs will be safety parameters, which, together with efficacy biomarkers, will be leveraged to select a dose for the Phase 2 part of the study. This second phase will be used to further define the safety profile and provide early markers of efficacy. Enabled by this latest regulatory approval and the recent U.S. IND clearance, as announced in July 2025, the Phase I/II study will recruit patients across the U.S. and Europe. For further information, contact: Purespring: Peter Mulcahycontact@ (0)20 3855 6324LinkedIn ICR Healthcare Amber Fennell, Sarah Elton-Farrpurespring@ Notes to Editors About Purespring Purespring is developing therapies to halt or prevent kidney disease, one of humankind's most poorly treated disease areas. Founded on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, Purespring is the first company to successfully treat kidney disease by targeting the podocyte, a specialised cell that is implicated in the majority of renal disease. Purespring's platform approach enables streamlined gene therapy development for both acquired and genetic renal diseases, offering the potential to halt, reverse and even cure both rare and common kidney diseases. The Company currently has a pipeline of programmes in development including the lead asset for treatment of IgA Nephropathy (IgAN) and other complement mediated kidney disease. The Company also has programmes for disease caused by mutations in the gene NPHS2, as well as other monogenic glomerular kidney diseases. Based in London, the Purespring team combines world-leading expertise in podocyte biology and kidney disease with a wealth of experience in gene therapies, anchored in a culture of diversity, creativity and delivery. Purespring is backed by leading biotech investors, including Syncona Limited, Sofinnova Partners, Gilde Healthcare, Forbion, and the British Business Bank and has raised £115m ($149m) to date. For more information please visit: and follow us on in to access your portfolio

Cognitive Impact From Dementia Risk Factors Greater in Women
Cognitive Impact From Dementia Risk Factors Greater in Women

Medscape

time19 minutes ago

  • Medscape

Cognitive Impact From Dementia Risk Factors Greater in Women

TORONTO — A number of modifiable risk factors are more common in women than in men and have a greater impact on cognition, an early look at new research showed. Six modifiable dementia risk factors were more prevalent in women, whereas only three were more common in men. Investigators also found that the impact on cognition from some of these factors was greater in women than in men, especially hearing loss and diabetes. However, the impact of these and other risk factors varied by age. Megan Fitzhugh, PhD The results suggest personalized health and lifestyle interventions should consider both sex and age, study author Megan Fitzhugh, PhD, assistant professor, Department of Neurosciences, University of California San Diego, told Medscape Medical News. 'Clinicians should familiarize themselves with the 14 identified modifiable risk factors, and if their patients have these risk factors, consider their sex and age, and try to target the behavior changes accordingly to minimize the impact on cognition and dementia risk,' Fitzhugh said. The findings were presented on July 28 at the Alzheimer's Association International Conference (AAIC) 2025. At Greater Risk It's well-known that women are at greater risk for dementia. The lifetime risk for Alzheimer's disease (AD) is 1 in 5 for women compared with 1 in 10 for men. Sex-specific factors such as pregnancy and menopause may contribute to this imbalance. But while many researchers tackle this issue from a biological perspective, Fitzhugh focuses on the effects of modifiable risk factors. She used the 2008 wave of the Health and Retirement study, an ongoing population-based study of a representative sample of American retirees and their spouses who complete questionnaire every 2 years (in 'waves'). After excluding anyone younger than 40 years and those without self-reported risk factor information, the study sample included 17,182 individuals. Fitzhugh concentrated on items included in the Lancet Report on Dementia Prevention. As reported by Medscape Medical News , 45% of dementia risk factors are potentially modifiable. Risk factors identified in the Lancet report include less education in early life (contributing 5% to risk); hearing loss (7%), elevated low density lipoprotein (LDL) cholesterol (7%), depression (3%), traumatic brain injury (3%), physical inactivity (2%), diabetes (2%), smoking (2%), hypertension (2%), obesity (1%), and excessive alcohol (1%) in midlife; and social isolation (5%), air pollution (3%), and vision loss (2%) in late life. Looking at prevalence, investigators found that six of the 14 risk factors were more common in women, including physical inactivity, depression, smoking, poor sleep, less education and poor vision (for example, glaucoma or cataracts). Only three risk factors were more common in men, including hearing loss, diabetes, and alcohol use. There was no difference in prevalence between men and women in high BMI, hypertension, and social isolation. Plotting Cognition The Health and Retirement Study also gathers data on global cognition (immediate recall, delayed recall, numeracy, etc.) using a 27-item scale. Fitzhugh separated mean cognitive scores for men and women and for three age groups (middle age: 40-59 years; middle to older age: 60-79 years; and oldest age: 80 years and over), then plotted risk factors in each group. The graphs she created illustrate the differences in cognitive performance between having and not having a risk factor for each sex. For example, the diabetes plot shows this risk factor has a much bigger impact on cognition in women. 'The line for men is relatively flat, so their cognition is really the same if they have diabetes or not, but for women, if they have diabetes, cognition is much lower compared to women who don't have diabetes', explained Fitzhugh. In addition to diabetes, other risk factors that have a greater cognitive impact on women included poor sleep, BMI, hypertension, poor vision, less education, and hearing loss. Along with high LDL, hearing loss is the largest modifiable risk factor, accounting for 7% of dementia risk, according to the Lancet Commission report. But even though more men have hearing loss across all ages, it appears to be more impactful on women in terms of cognition, said Fitzhugh. 'Maybe we should be targeting women with hearing loss in middle to older age, making sure they get hearing aids,' she said. Elsewhere in her research, Fitzhugh found women with hearing loss have a greater risk for dementia than men with hearing loss. 'There's something about hearing loss in women that is particularly detrimental.' The cognitive impact of risk factors also varies by age, investigators found. Among women, the impact of hearing loss was greatest in middle to older age. Poor sleep only had a significant impact in middle age, which coincides with the menopause transition. And in the oldest age, less education was the only risk factor to have a significant impact on cognition. In men, only smoking had a greater cognitive impact, but interestingly, only in the older age group. 'The way I think about age in this study is it's telling us when, potentially, we should be targeting these risk factors,' said Fitzhugh. She recognizes this is 'just a snapshot' in time and said she'd like to 'map out' how risk factors impact cognition over time. Commenting on the research, Liisa Galea, PhD, Treliving Family Chair in Women's Mental Health, Centre for Addiction and Mental Health, and professor of psychiatry, University of Toronto, Toronto, Ontario, Canada, said that more modifiable factors are associated with cognition in females than males is 'most surprising.' 'Clearly these factors are important for everyone, but we need more targeted messaging to women across the lifespan about the importance of these variables for their brain health,' Galea said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store